| |
 |
|
Class Information
Number: 424/185.1
Name: Drug, bio-affecting and body treating compositions > Antigen, epitope, or other immunospecific immunoeffector (e.g., immunospecific vaccine, immunospecific stimulator of cell-mediated immunity, immunospecific tolerogen, immunospecific immunosuppressor, etc.) > Amino acid sequence disclosed in whole or in part; or conjugate, complex, or fusion protein or fusion polypeptide including the same
Description: Subject matter wherein an amino acid sequence specifying an antigen, an epitope, or another immunospecific immunoeffector is disclosed in whole or in part, wherein the disclosed amino acid sequence may be part of a conjugate, a complex, or a fusion protein or fusion polypeptide.
Sub-classes under this class:
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7371809 |
Pharmacologically active antiviral peptides |
May. 13, 2008 |
| 7371388 |
Treatment of Sjogren's syndrome by administration of TR18 polypeptides |
May. 13, 2008 |
| 7368537 |
Subunit vaccine against respiratory syncytial virus infection |
May. 6, 2008 |
| 7368533 |
Polypeptide autoantigens associated with endometriosis |
May. 6, 2008 |
| 7368261 |
Conserved Neisserial antigens |
May. 6, 2008 |
| 7368119 |
Compositions and methods for WT1 specific immunotherapy |
May. 6, 2008 |
| 7365156 |
PRO1316 polypeptides |
Apr. 29, 2008 |
| 7365155 |
Immunoregulator |
Apr. 29, 2008 |
| 7364743 |
Nucleotide sequence encoding PTD and CEA fusion protein, TAT-CEA fusion protein, anti-tumor vaccine and pharmaceutical composition for treating tumor comprising the fusion protein |
Apr. 29, 2008 |
| 7364741 |
Peptides of human Papilloma virus for use in human T cell response inducing compositions |
Apr. 29, 2008 |
| 7364740 |
Molecular differences between species of the M. tuberculosis complex |
Apr. 29, 2008 |
| 7361637 |
Hypotensors |
Apr. 22, 2008 |
| 7361352 |
Influenza immunogen and vaccine |
Apr. 22, 2008 |
| 7361351 |
Method for sensitizing bovine mammary cells to respond to LPS |
Apr. 22, 2008 |
| 7361350 |
Use of an IL-1 antagonist for treating arthritis |
Apr. 22, 2008 |
| 7361349 |
Peptide, immunogenic composition and vaccine or medical preparation, a method to immunize animals against the hormone LHRH, and analogs of the LHRH tandem repeat peptide and their use as vacci |
Apr. 22, 2008 |
| 7354991 |
Peptides for the diagnosis of schizophrenia |
Apr. 8, 2008 |
| 7354588 |
Functional derivatives of ICAM-1 with altered ability to bind LFA-1 or HRV |
Apr. 8, 2008 |
| 7351686 |
Method for neuronal protection in amyotrophic lateral sclerosis by a vaccine comprising Copolymer-1 or Copolymer-1 related peptides |
Apr. 1, 2008 |
| 7351570 |
HDV nucleic acid molecules and applications thereof |
Apr. 1, 2008 |
| 7351416 |
Vaccines comprising acapsular P. multocida hyaE deletion mutants |
Apr. 1, 2008 |
| 7348405 |
PRO10274 polypeptides |
Mar. 25, 2008 |
| 7348010 |
Vaccine against cancer diseases that are associated with the her-2/neu oncogene |
Mar. 25, 2008 |
| 7348009 |
Recombinant allergen with reduced enzymatic activity |
Mar. 25, 2008 |
| 7348007 |
Mage C2 antigenic peptides and uses thereof |
Mar. 25, 2008 |
| 7344724 |
UspA1 and UspA2 antigens of Moraxella catarrhalis |
Mar. 18, 2008 |
| 7344721 |
Polypeptide for the treatment of cancer and a method for preparation thereof |
Mar. 18, 2008 |
| 7341730 |
Inhibitors of angiogenesis and tumor growth |
Mar. 11, 2008 |
| 7341726 |
Modified HCV peptide immunogens |
Mar. 11, 2008 |
| 7341724 |
Polypeptide for the treatment of cancer and a method for preparation thereof |
Mar. 11, 2008 |
| 7339024 |
PRO1772 polypeptides |
Mar. 4, 2008 |
| 7338766 |
Compositions and methods for treating malaria with cupredoxin and cytochrome |
Mar. 4, 2008 |
| 7335737 |
Ovary-specific genes and proteins |
Feb. 26, 2008 |
| 7335733 |
Tissue cement proteins from Rhipicephalus appendiculatus |
Feb. 26, 2008 |
| 7335640 |
Administration of hypocretin-1 for treatment of narcolepsy |
Feb. 26, 2008 |
| 7335637 |
Biglycan and related therapeutics and methods of use |
Feb. 26, 2008 |
| 7335636 |
SPRR1A and axonal regeneration |
Feb. 26, 2008 |
| 7335505 |
Materials and methods relating to protein aggregation in neurodegenerative disease |
Feb. 26, 2008 |
| 7335368 |
BVH-A2 and BVH-A3 antigens of group B Streptococcus |
Feb. 26, 2008 |
| 7335360 |
Method and device for detecting feline immunodeficiency virus |
Feb. 26, 2008 |
| 7335350 |
Chemokines mutants having improved oral bioavailability |
Feb. 26, 2008 |
| 7332595 |
DNA sequences encoding peptide sequences specific for the hepatic stages of P. falciparum bearing epitopes capable of stimulating the T lymphocytes |
Feb. 19, 2008 |
| 7332473 |
Peptides and medicinal compositions containing the same |
Feb. 19, 2008 |
| 7332172 |
Transformed bacteria producing CS6 antigens as vaccines |
Feb. 19, 2008 |
| 7332170 |
Classical swine fever virus virulence determinant and a novel classical swine fever vaccine |
Feb. 19, 2008 |
| 7332167 |
Nucleic acid and amino acid sequences of hemoglobin-response genes in Candida albicans and the use of reagents derived from these sequences in the diagnosis of disseminated Candida albicans in |
Feb. 19, 2008 |
| 7329730 |
PRO4348 polypeptides |
Feb. 12, 2008 |
| 7329638 |
Drug delivery compositions |
Feb. 12, 2008 |
| 7329500 |
Moraxella (Branhamella) catarrhalis polypeptides and corresponding DNA fragments |
Feb. 12, 2008 |
| 7329410 |
Compositions and method for WT1 specific immunotherapy |
Feb. 12, 2008 |
|
|
|
